Thrivent Financial for Lutherans raised its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) by 33.6% during the third quarter, HoldingsChannel reports. The firm owned 234,890 shares of the company’s stock after acquiring an additional 59,025 shares during the quarter. Thrivent Financial for Lutherans’ holdings in VanEck Pharmaceutical ETF were worth $22,322,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Optimum Investment Advisors acquired a new stake in VanEck Pharmaceutical ETF in the second quarter valued at about $27,000. GPS Wealth Strategies Group LLC bought a new position in shares of VanEck Pharmaceutical ETF in the second quarter worth about $42,000. CWM LLC acquired a new stake in shares of VanEck Pharmaceutical ETF in the 2nd quarter valued at approximately $55,000. International Assets Investment Management LLC bought a new stake in shares of VanEck Pharmaceutical ETF during the 2nd quarter valued at approximately $86,000. Finally, Comerica Bank increased its position in VanEck Pharmaceutical ETF by 39.4% during the 1st quarter. Comerica Bank now owns 1,337 shares of the company’s stock worth $121,000 after purchasing an additional 378 shares in the last quarter.
VanEck Pharmaceutical ETF Price Performance
Shares of NASDAQ:PPH opened at $86.87 on Wednesday. VanEck Pharmaceutical ETF has a one year low of $77.04 and a one year high of $99.51. The company has a market cap of $641.97 million, a price-to-earnings ratio of 21.04 and a beta of 0.72. The firm has a 50 day simple moving average of $93.27 and a 200 day simple moving average of $93.05.
VanEck Pharmaceutical ETF Profile
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.
Featured Articles
- Five stocks we like better than VanEck Pharmaceutical ETF
- How to Invest in Small Cap Stocks
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- What is a Low P/E Ratio and What Does it Tell Investors?
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- What Are Dividend Achievers? An Introduction
- 3 Hot Stock Trends to Ride Into 2025
Want to see what other hedge funds are holding PPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report).
Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.
